News
-
Most new TCM drugs approved in 5 years
China granted market approval for 12 new traditional Chinese medicine products last year, the largest figure in the past five years, according to a report released on Thursday.Jul 19,2022 -
Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
Objective: To observe the effect of Danhong injection (DHI) on perioperative metabolomics of unstable angina pectoris (UA) with blood stasis syndrome.Jul 8,2022 -
Andrographolide protects retinal ganglion cells in rats with glaucoma by regulating the Bcl-2/Bax/caspase-3 signaling pathway
Objective: The aim is to investigate the protective effect of andrographolide (AP) on retinal ganglion cells (RGC) in rats with glaucoma and its mechanism. Methods: ninety-six adult male Wistar rats were randomly divided into normal control (NC) group, chronic ocular hypertension (CHOT) group, vehicle group, and AP group. The density of RGCs and the number of apoptotic cells in retinal slices were evaluated, and the function of RGC was evaluated by photopic negative wave response (PhNR). The expression of Bcl-2, Bax, and caspase-3 in the retina was detected.Jul 8,2022 -
Growth promotion effects of Bacillus subtilis on Bletilla striata seedlings
Objective: The objective of the study is to study the growth promotion effects of Bacillus subtilis inoculants on the growth of Bletilla striata seedlings.Jul 8,2022 -
Research progress on the pharmacological mechanisms of chinese medicines that tonify Qi and activate blood against cerebral ischemia/reperfusion injury
Cerebral ischemia-reperfusion injury (CIRI) refers to a pathological phenomenon that aggravates the injury after the restoration of blood perfusion and oxygen supply to the cerebral ischemia-induced tissues and organs, with a relatively high incidence.Jul 8,2022 -
Characteristics of traditional chinese medicine syndrome in patients with coronary heart disease at different disease stages
Coronary atherosclerotic heart disease (CHD) has a high incidence, disability rate, and mortality rate, which severely affect people's health, work, and life. Based on its clinical manifestations, traditional Chinese medicine (TCM) has classified CHD as “chest impediment” and “heart pain” for the treatment.Jul 8,2022
